DILLARDS INC-CL A (DDS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:DDS - US2540671011 - Common Stock
675.04 USD
-7.14 (-1.05%)
Taking everything into account, DDS scores 6 out of 10 in our fundamental rating. DDS was compared to 30 industry peers in the Broadline Retail industry. Both the health and profitability get an excellent rating, making DDS a very profitable company, without any liquidiy or solvency issues. DDS has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
DDS had positive earnings in the past year.
DDS had a positive operating cash flow in the past year.
Of the past 5 years DDS 4 years were profitable.
DDS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of DDS (13.51%) is better than 96.67% of its industry peers.
DDS has a Return On Equity of 28.40%. This is amongst the best in the industry. DDS outperforms 93.33% of its industry peers.
DDS has a Return On Invested Capital of 19.86%. This is amongst the best in the industry. DDS outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for DDS is significantly above the industry average of 9.35%.
The 3 year average ROIC (28.72%) for DDS is well above the current ROIC(19.86%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.51% | ||
| ROE | 28.4% | ||
| ROIC | 19.86% |
ROA(3y)21.67%
ROA(5y)17.85%
ROE(3y)44.12%
ROE(5y)37.36%
ROIC(3y)28.72%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 8.77%, DDS belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
DDS's Profit Margin has improved in the last couple of years.
DDS's Operating Margin of 10.56% is fine compared to the rest of the industry. DDS outperforms 73.33% of its industry peers.
In the last couple of years the Operating Margin of DDS has grown nicely.
Looking at the Gross Margin, with a value of 40.22%, DDS is doing worse than 66.67% of the companies in the same industry.
DDS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.56% | ||
| PM (TTM) | 8.77% | ||
| GM | 40.22% |
OM growth 3Y-13.46%
OM growth 5Y33.93%
PM growth 3Y-11.56%
PM growth 5Y38.75%
GM growth 3Y-2.28%
GM growth 5Y4.06%
2. Health
2.1 Basic Checks
DDS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for DDS has been reduced compared to 1 year ago.
DDS has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, DDS has an improved debt to assets ratio.
2.2 Solvency
The Debt to FCF ratio of DDS is 0.67, which is an excellent value as it means it would take DDS, only 0.67 years of fcf income to pay off all of its debts.
DDS has a Debt to FCF ratio of 0.67. This is amongst the best in the industry. DDS outperforms 86.67% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that DDS is not too dependend on debt financing.
DDS's Debt to Equity ratio of 0.21 is fine compared to the rest of the industry. DDS outperforms 63.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 0.67 | ||
| Altman-Z | N/A |
ROIC/WACC2.32
WACC8.56%
2.3 Liquidity
A Current Ratio of 2.19 indicates that DDS has no problem at all paying its short term obligations.
The Current ratio of DDS (2.19) is better than 66.67% of its industry peers.
DDS has a Quick Ratio of 1.00. This is a normal value and indicates that DDS is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.00, DDS is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.19 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
DDS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.17%.
DDS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 57.80% yearly.
Looking at the last year, DDS shows a decrease in Revenue. The Revenue has decreased by -1.07% in the last year.
The Revenue has been growing slightly by 0.77% on average over the past years.
EPS 1Y (TTM)-5.17%
EPS 3Y-5.24%
EPS 5Y57.8%
EPS Q2Q%7.5%
Revenue 1Y (TTM)-1.07%
Revenue growth 3Y-0.17%
Revenue growth 5Y0.77%
Sales Q2Q%2.74%
3.2 Future
The Earnings Per Share is expected to decrease by -12.51% on average over the next years. This is quite bad
Based on estimates for the next years, DDS will show a decrease in Revenue. The Revenue will decrease by -0.98% on average per year.
EPS Next Y-8.66%
EPS Next 2Y-7.97%
EPS Next 3Y-12.51%
EPS Next 5YN/A
Revenue Next Year-0.23%
Revenue Next 2Y-0.5%
Revenue Next 3Y-0.98%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 18.32 indicates a rather expensive valuation of DDS.
76.67% of the companies in the same industry are more expensive than DDS, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.11, DDS is valued a bit cheaper.
With a Price/Forward Earnings ratio of 21.61, DDS is valued on the expensive side.
DDS's Price/Forward Earnings is on the same level as the industry average.
DDS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 36.21.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.32 | ||
| Fwd PE | 21.61 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DDS indicates a somewhat cheap valuation: DDS is cheaper than 66.67% of the companies listed in the same industry.
66.67% of the companies in the same industry are more expensive than DDS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.49 | ||
| EV/EBITDA | 11.02 |
4.3 Compensation for Growth
The excellent profitability rating of DDS may justify a higher PE ratio.
DDS's earnings are expected to decrease with -12.51% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.32
EPS Next 2Y-7.97%
EPS Next 3Y-12.51%
5. Dividend
5.1 Amount
With a yearly dividend of 0.18%, DDS is not a good candidate for dividend investing.
DDS's Dividend Yield is a higher than the industry average which is at 14.88.
With a Dividend Yield of 0.18, DDS pays less dividend than the S&P500 average, which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.18% |
5.2 History
On average, the dividend of DDS grows each year by 111.67%, which is quite nice.
DDS has paid a dividend for at least 10 years, which is a reliable track record.
DDS has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)111.67%
Div Incr Years14
Div Non Decr Years34
5.3 Sustainability
71.18% of the earnings are spent on dividend by DDS. This is not a sustainable payout ratio.
The Dividend Rate of DDS has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP71.18%
EPS Next 2Y-7.97%
EPS Next 3Y-12.51%
NYSE:DDS (12/2/2025, 3:04:09 PM)
675.04
-7.14 (-1.05%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)
Earnings (Next)
Inst Owners71.33%
Inst Owner Change-2.86%
Ins Owners23.24%
Ins Owner Change-0.28%
Market Cap10.54B
Revenue(TTM)6.63B
Net Income(TTM)580.85M
Analysts45.45
Price Target440.3 (-34.77%)
Short Float %11.33%
Short Ratio7.44
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.18% |
Yearly Dividend25.75
Dividend Growth(5Y)111.67%
DP71.18%
Div Incr Years14
Div Non Decr Years34
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.62%
Min EPS beat(2)22.99%
Max EPS beat(2)34.25%
EPS beat(4)4
Avg EPS beat(4)26.67%
Min EPS beat(4)12.59%
Max EPS beat(4)36.84%
EPS beat(8)7
Avg EPS beat(8)17.05%
EPS beat(12)11
Avg EPS beat(12)23.25%
EPS beat(16)15
Avg EPS beat(16)42.18%
Revenue beat(2)2
Avg Revenue beat(2)1.37%
Min Revenue beat(2)0.12%
Max Revenue beat(2)2.62%
Revenue beat(4)3
Avg Revenue beat(4)1.26%
Min Revenue beat(4)-0.64%
Max Revenue beat(4)2.94%
Revenue beat(8)5
Avg Revenue beat(8)0.15%
Revenue beat(12)7
Avg Revenue beat(12)0.35%
Revenue beat(16)11
Avg Revenue beat(16)1.43%
PT rev (1m)19.08%
PT rev (3m)19.08%
EPS NQ rev (1m)-6.5%
EPS NQ rev (3m)-6.6%
EPS NY rev (1m)-0.4%
EPS NY rev (3m)10.23%
Revenue NQ rev (1m)1%
Revenue NQ rev (3m)1%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.03%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.32 | ||
| Fwd PE | 21.61 | ||
| P/S | 1.59 | ||
| P/FCF | 13.49 | ||
| P/OCF | 12.11 | ||
| P/B | 5.15 | ||
| P/tB | 5.15 | ||
| EV/EBITDA | 11.02 |
EPS(TTM)36.84
EY5.46%
EPS(NY)31.24
Fwd EY4.63%
FCF(TTM)50.05
FCFY7.41%
OCF(TTM)55.76
OCFY8.26%
SpS424.44
BVpS131.01
TBVpS131.01
PEG (NY)N/A
PEG (5Y)0.32
Graham Number329.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.51% | ||
| ROE | 28.4% | ||
| ROCE | 24.53% | ||
| ROIC | 19.86% | ||
| ROICexc | 37.31% | ||
| ROICexgc | 37.31% | ||
| OM | 10.56% | ||
| PM (TTM) | 8.77% | ||
| GM | 40.22% | ||
| FCFM | 11.79% |
ROA(3y)21.67%
ROA(5y)17.85%
ROE(3y)44.12%
ROE(5y)37.36%
ROIC(3y)28.72%
ROIC(5y)N/A
ROICexc(3y)44.45%
ROICexc(5y)N/A
ROICexgc(3y)44.45%
ROICexgc(5y)N/A
ROCE(3y)35.47%
ROCE(5y)N/A
ROICexgc growth 3Y-15.2%
ROICexgc growth 5Y43.2%
ROICexc growth 3Y-15.2%
ROICexc growth 5Y43.2%
OM growth 3Y-13.46%
OM growth 5Y33.93%
PM growth 3Y-11.56%
PM growth 5Y38.75%
GM growth 3Y-2.28%
GM growth 5Y4.06%
F-Score5
Asset Turnover1.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 0.67 | ||
| Debt/EBITDA | 0.49 | ||
| Cap/Depr | 50.63% | ||
| Cap/Sales | 1.35% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 99.37% | ||
| Profit Quality | 134.49% | ||
| Current Ratio | 2.19 | ||
| Quick Ratio | 1 | ||
| Altman-Z | N/A |
F-Score5
WACC8.56%
ROIC/WACC2.32
Cap/Depr(3y)64.95%
Cap/Depr(5y)54.93%
Cap/Sales(3y)1.75%
Cap/Sales(5y)1.64%
Profit Quality(3y)99.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.17%
EPS 3Y-5.24%
EPS 5Y57.8%
EPS Q2Q%7.5%
EPS Next Y-8.66%
EPS Next 2Y-7.97%
EPS Next 3Y-12.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.07%
Revenue growth 3Y-0.17%
Revenue growth 5Y0.77%
Sales Q2Q%2.74%
Revenue Next Year-0.23%
Revenue Next 2Y-0.5%
Revenue Next 3Y-0.98%
Revenue Next 5YN/A
EBIT growth 1Y-8.11%
EBIT growth 3Y-13.61%
EBIT growth 5Y34.96%
EBIT Next Year22.74%
EBIT Next 3Y-0.39%
EBIT Next 5YN/A
FCF growth 1Y10.49%
FCF growth 3Y-19.67%
FCF growth 5Y18.42%
OCF growth 1Y3.99%
OCF growth 3Y-17.68%
OCF growth 5Y14.36%
DILLARDS INC-CL A / DDS FAQ
What is the fundamental rating for DDS stock?
ChartMill assigns a fundamental rating of 6 / 10 to DDS.
What is the valuation status for DDS stock?
ChartMill assigns a valuation rating of 4 / 10 to DILLARDS INC-CL A (DDS). This can be considered as Fairly Valued.
How profitable is DILLARDS INC-CL A (DDS) stock?
DILLARDS INC-CL A (DDS) has a profitability rating of 8 / 10.
What are the PE and PB ratios of DILLARDS INC-CL A (DDS) stock?
The Price/Earnings (PE) ratio for DILLARDS INC-CL A (DDS) is 18.32 and the Price/Book (PB) ratio is 5.15.
Can you provide the financial health for DDS stock?
The financial health rating of DILLARDS INC-CL A (DDS) is 7 / 10.